SCHEMBL368803

SCHEMBL368803

Cn1c(Nc2ccc(F)cc2)ncc(-c2ccc(Oc3ncnc4cc5c(cc34)OCCOCCOCCO5)cn2)c1=O.Cn1c(Nc2ccc(F)cc2)ncc(-c2ccc(Oc3ncnc4cc5c(cc34)OCO5)cn2)c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 11/20 0.53
KDR P35968 10/20 0.53
MST1R Q04912 3/20 0.53
HGF P14210 2/20 0.53
RPS6KB1 P23443 2/20 0.53
TEK Q02763 2/20 0.53
BTK Q06187 2/20 0.53
AURKA O14965 1/20 0.53
RPS6KA5 O75582 1/20 0.53
LCK P06239 1/20 0.53
PIM1 P11309 1/20 0.53
MAPK9 P45984 1/20 0.53
BRAF P15056 2/20 0.41
EGFR P00533 4/20 0.40
JAK2 O60674 1/20 0.40
FLT1 P17948 1/20 0.40
FGFR2 P21802 1/20 0.40
FLT4 P35916 1/20 0.40
PDGFRB P09619 3/20 0.38
KIT P10721 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368467 0.98 KDR (0.55) METKDRMST1RHGFRPS6KB1
SCHEMBL368940 0.98 KDR (0.55) METKDRMST1RHGFRPS6KB1
SCHEMBL368364 0.96 KDR (0.52) METKDRMST1RHGFRPS6KB1
SCHEMBL369342 0.93 KDR (0.52) METKDRMST1RHGFRPS6KB1
SCHEMBL368396 0.91 KDR (0.53) METKDRMST1RHGFRPS6KB1
SCHEMBL368772 0.89 KDR (0.44) METKDRMST1RHGFRPS6KB1
SCHEMBL361179 0.86 MET (0.69) METKDRMST1RHGFRPS6KB1
SCHEMBL369483 0.86 KDR (0.49) METKDRMST1RHGFRPS6KB1
SCHEMBL363057 0.81 MET (0.66) METKDRMST1RHGFRPS6KB1
SCHEMBL14937303 0.80 RAF1 (0.38) METKDRMST1RHGFRPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593462-A1 NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS Zhejiang Beta Pharma Inc. (CN) 2013-05-22 EP disclosed
WO-2012006960-A1 NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS ZHEJIANG BETA PHARMA INC. (CN) 2012-01-19 WO disclosed